Ten Years of Improving Acute Stroke Management in a Metropolitan Area: A Population-Based Quantification of Quality Indicators.


Journal

European neurology
ISSN: 1421-9913
Titre abrégé: Eur Neurol
Pays: Switzerland
ID NLM: 0150760

Informations de publication

Date de publication:
2022
Historique:
received: 15 12 2020
accepted: 11 07 2021
pubmed: 25 11 2021
medline: 7 4 2022
entrez: 24 11 2021
Statut: ppublish

Résumé

Rapid access to acute stroke treatment improves clinical outcomes in patients with ischemic stroke. We aimed to shorten the time to admission and to acute stroke treatment for patients with acute stroke in the Hamburg metropolitan area by collaborative multilevel measures involving all hospitals with stroke units, the Emergency Medical Services (EMS), and health-care authorities. In 2007, an area-wide stroke care quality project was initiated. The project included mandatory admission of all stroke patients in Hamburg exclusively to hospitals with stroke units, harmonized acute treatment algorithms among all hospitals, repeated training of the EMS staff, a multimedia educational campaign, and a mandatory stroke care quality monitoring system based on structured data assessment and quality indicators for procedural measures. We analyzed data of all patients with acute stroke who received inhospital treatment in the city of Hamburg during the evaluation period from the quality assurance database data and evaluated trends of key quality indicators over time. From 2007 to 2016, a total of 83,395 patients with acute stroke were registered. During this period, the proportion of patients admitted within ≤3 h from symptom onset increased over time from 27.8% in 2007 to 35.2% in 2016 (p < 0.001). The proportion of patients who received rapid thrombolysis (within ≤30 min after admission) increased from 7.7 to 54.1% (p < 0.001). Collaborative stroke care quality projects are suitable and effective to improve acute stroke care.

Sections du résumé

BACKGROUND AND PURPOSE
Rapid access to acute stroke treatment improves clinical outcomes in patients with ischemic stroke. We aimed to shorten the time to admission and to acute stroke treatment for patients with acute stroke in the Hamburg metropolitan area by collaborative multilevel measures involving all hospitals with stroke units, the Emergency Medical Services (EMS), and health-care authorities.
METHODS
In 2007, an area-wide stroke care quality project was initiated. The project included mandatory admission of all stroke patients in Hamburg exclusively to hospitals with stroke units, harmonized acute treatment algorithms among all hospitals, repeated training of the EMS staff, a multimedia educational campaign, and a mandatory stroke care quality monitoring system based on structured data assessment and quality indicators for procedural measures. We analyzed data of all patients with acute stroke who received inhospital treatment in the city of Hamburg during the evaluation period from the quality assurance database data and evaluated trends of key quality indicators over time.
RESULTS
From 2007 to 2016, a total of 83,395 patients with acute stroke were registered. During this period, the proportion of patients admitted within ≤3 h from symptom onset increased over time from 27.8% in 2007 to 35.2% in 2016 (p < 0.001). The proportion of patients who received rapid thrombolysis (within ≤30 min after admission) increased from 7.7 to 54.1% (p < 0.001).
CONCLUSIONS
Collaborative stroke care quality projects are suitable and effective to improve acute stroke care.

Identifiants

pubmed: 34818228
pii: 000518428
doi: 10.1159/000518428
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-49

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Anna Alegiani (A)

Department of Neurology, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Michael Rosenkranz (M)

Institute of Medical Biometry and Epidemiology University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Leonie Schmitz (L)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Susanne Lezius (S)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Günter Seidel (G)

Department of Neurology, Albertinen Krankenhaus, Hamburg, Germany.

Volker Heßelmann (V)

Department of Neurology and Neuroradiology, Asklepios Hospital Nord, Hamburg, Germany.

Rudolf Töpper (R)

Department of Neurology and Neuroradiology, Asklepios Hospital Nord, Hamburg, Germany.

Christoph Terborg (C)

Department of Neurology, Asklepios Hospital Harburg, Hamburg, Germany.

Peter P Urban (PP)

Department of Neurology, Asklepios Hospital St. Georg, Hamburg, Germany.

Roland Brüning (R)

Department of Neurology and Radiology and Neuroradiology, Asklepios Hospital Barmbek, Hamburg, Germany.

Jan Höltje (J)

Department of Neurology and Radiology and Neuroradiology, Asklepios Hospital Barmbek, Hamburg, Germany.

Florian Lienau (F)

Department of Neurology, Asklepios Hospital Barmbek, Hamburg, Germany.

Christian Arning (C)

Asklepios Hospital Barmbek, Marienkrankenhaus, Hamburg, Germany.

Lars Marquardt (L)

Asklepios Hospital Barmbek, Marienkrankenhaus, Hamburg, Germany.

Axel Müller-Jensen (A)

University Department of Neurology, Asklepios Hospital Hamburg Wandsbek, Faculty of Medicine, Semmelweis University Campus Hamburg, Hamburg, Germany.

Joachim Röther (J)

University Department of Neurology, Asklepios Hospital Hamburg Wandsbek, Faculty of Medicine, Semmelweis University Campus Hamburg, Hamburg, Germany.

Bernd Eckert (B)

Department of Neurology and Neuroradiology, Asklepios Hospital Altona, Hamburg, Germany.

Antonia Zapf (A)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jens Fiehler (J)

Department of Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Götz Thomalla (G)

Department of Neurology, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian Gerloff (C)

Department of Neurology, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH